Philogen Stock Quote PHIL - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

20.80

Bid

20.80

Ask

21.00

Volume

1,831

20.80 Day's Range 21.00

15.50 52 Week Range 21.60

Market Cap

840.27M

Previous Close

20.80

Open

21.00

Last Trade

106

20.8

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

10,195

Shares Outstanding

40,397,605

Dividend Yield

PE Ratio

Earnings Per Share (EPS)

Revenue

Net Profit

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.philogen.com

Headquarters

Siena, Siena, Ita

Founded

1970

Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 20.80 €. Over the last year, Philogen shares have traded in a share price range of 15.50 € to 21.60 €.

Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 840.27 € million.

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	20.8	21	20.4	6085	20.82955927	DE
4	0.6	2.9702970297	20.2	21	19.8	6227	20.4132426	DE
12	2.45	13.3514986376	18.35	21.6	17.6	10195	19.93863373	DE
26	2.2	11.8279569892	18.6	21.6	16.3	10749	18.63587332	DE
52	4.95	31.2302839117	15.85	21.6	15.5	11968	18.12189509	DE
156	7.8	60	13	21.6	13	10222	15.93208412	DE
260	3.8	22.3529411765	17	21.6	12.6	12845	15.75921511	DE

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 3.12 (352.96%)	107.19M
CMAXCareMax Inc	$ 4.03 (155.06%)	41.17M
SERVServe Robotics Inc	$ 12.065 (59.80%)	104.15M
NUKKNukkleus Inc	$ 0.419 (30.94%)	7.04M
SAVACassava Sciences Inc	$ 13.13 (30.26%)	7.41M
LGCBLinkage Global Inc	$ 3.6899 (-29.24%)	116.37k
CGBSCrown LNG Holdings Ltd	$ 1.0697 (-24.13%)	1.67M
MEDSTRxADE Health Inc	$ 11.25 (-23.68%)	78.05k
SLNASelina Hospitality PLC	$ 0.0366 (-22.62%)	40.5M
NWGLNature Wood Group Ltd	$ 2.005 (-19.15%)	72.88k
NVDANVIDIA Corporation	$ 120.86 (2.48%)	116.59M
NCPLNetcapital Inc	$ 0.1113 (7.02%)	107.94M
MIRAMIRA Pharmaceuticals Inc	$ 3.12 (352.96%)	107.19M
SERVServe Robotics Inc	$ 12.065 (59.80%)	104.15M
SQQQProShares UltraPro Short QQQ	$ 8.31 (-1.77%)	99.98M

Symbol

Price

Vol.